Round Table Services’s Lexicon Pharmaceuticals LXRX Stock Holding History

Round Table Services’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-21,611	Closed	-$185K	–	121
2018 Q1	$185K	Hold	21,611	–	–	0.07%	103
2017 Q4	$214K	Hold	21,611	–	–	0.07%	90
2017 Q3	$266K	Hold	21,611	–	–	0.1%	77
2017 Q2	$356K	Hold	21,611	–	–	0.13%	62
2017 Q1	$310K	Hold	21,611	–	–	0.11%	64
2016 Q4	$299K	Hold	21,611	–	–	0.12%	67
2016 Q3	$391K	Hold	21,611	–	–	0.23%	46
2016 Q2	$310K	Hold	21,611	–	–	0.17%	65
2016 Q1	$258K	Hold	21,611	–	–	0.16%	74
2015 Q4	$288K	Hold	21,611	–	–	0.21%	59
2015 Q3	$232K	Hold	21,611	–	–	0.17%	72
2015 Q2	$174K	Hold	21,611	–	–	0.14%	70
2015 Q1	$143K	Hold	21,611	–	–	0.11%	69
2014 Q4	$138K	Hold	21,611	–	–	0.11%	55
2014 Q3	$213K	Hold	21,611	–	–	0.18%	44
2014 Q2	$244K	Hold	21,611	–	–	0.2%	44
2014 Q1	$262K	Hold	21,611	–	–	0.29%	44
2013 Q4	$272K	Buy	+21,611	New	+$344K	0.29%	40

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CLM

ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return

SGA

Sector Gamma AS Oslo, Norway $461M AUM 33.26% 1-Year Est. Return

Round Table Services's LXRX Position: Q2 2018 in Review

Round Table Services sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2018, closing a stake of 21,611 shares — an estimated $185K sold.

Round Table Services first reported a position in LXRX in Q4 2013 and held it in 18 quarters. The position peaked at $391K in Q3 2016. 121 funds tracked by Wall St. Rank hold LXRX as of Q2 2018.

Round Table Services reported no remaining Lexicon Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Round Table Services sold 21,611 Lexicon Pharmaceuticals shares in Q2 2018, an estimated $185K.
Round Table Services first reported a position in Lexicon Pharmaceuticals in Q4 2013 and held it in 18 quarters.
Round Table Services's Lexicon Pharmaceuticals position peaked at $391K in Q3 2016.
121 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2018.

Based on Round Table Services's 13F filing for Q2 2018, filed 19 Jul 2018.